HEADER HYDROLASE 21-JAN-23 8I4S TITLE THE COMPLEX STRUCTURE OF SARS-COV-2 MPRO WITH D8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORF1A POLYPROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: ORF1AB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS INHIBITOR, COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.LU REVDAT 1 29-NOV-23 8I4S 0 JRNL AUTH K.ZHANG,T.WANG,M.LI,M.LIU,H.TANG,L.WANG,K.YE,J.YANG,S.JIANG, JRNL AUTH 2 Y.XIAO,Y.XIE,M.LU,X.ZHANG JRNL TITL DISCOVERY OF QUINAZOLIN-4-ONE-BASED NON-COVALENT INHIBITORS JRNL TITL 2 TARGETING THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS JRNL TITL 3 2 MAIN PROTEASE (SARS-COV-2 M PRO ). JRNL REF EUR.J.MED.CHEM. V. 257 15487 2023 JRNL REFN ISSN 0223-5234 JRNL PMID 37257212 JRNL DOI 10.1016/J.EJMECH.2023.115487 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 35746 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.820 REMARK 3 FREE R VALUE TEST SET COUNT : 2081 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.4100 - 5.4200 0.96 2232 140 0.1632 0.1922 REMARK 3 2 5.4200 - 4.3100 0.96 2200 136 0.1475 0.1660 REMARK 3 3 4.3000 - 3.7600 0.97 2238 137 0.1518 0.2086 REMARK 3 4 3.7600 - 3.4200 0.96 2235 134 0.1688 0.1932 REMARK 3 5 3.4200 - 3.1700 0.97 2261 141 0.1920 0.2014 REMARK 3 6 3.1700 - 2.9900 0.98 2280 138 0.1947 0.2453 REMARK 3 7 2.9900 - 2.8400 0.97 2227 139 0.2053 0.2505 REMARK 3 8 2.8400 - 2.7100 0.97 2253 145 0.2075 0.2685 REMARK 3 9 2.7100 - 2.6100 0.97 2228 139 0.2191 0.2563 REMARK 3 10 2.6100 - 2.5200 0.98 2273 136 0.2114 0.2550 REMARK 3 11 2.5200 - 2.4400 0.97 2250 134 0.2253 0.2951 REMARK 3 12 2.4400 - 2.3700 0.98 2275 143 0.2231 0.2932 REMARK 3 13 2.3700 - 2.3100 0.97 2282 141 0.2248 0.2886 REMARK 3 14 2.3100 - 2.2500 0.97 2214 139 0.2413 0.2687 REMARK 3 15 2.2500 - 2.2000 0.96 2217 139 0.2474 0.2896 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.236 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.893 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2403 REMARK 3 ANGLE : 1.022 3270 REMARK 3 CHIRALITY : 0.052 364 REMARK 3 PLANARITY : 0.006 422 REMARK 3 DIHEDRAL : 19.750 853 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8I4S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1300034881. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-AUG-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35746 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 42.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 20,000, 0.1 M MES MONOHYDRATE REMARK 280 (PH 6.5), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.18200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.66600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.18200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 40.66600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -43.25702 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 93.86188 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 530 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 584 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 621 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 GLY A -17 REMARK 465 SER A -16 REMARK 465 SER A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 SER A -8 REMARK 465 SER A -7 REMARK 465 GLY A -6 REMARK 465 MET A -5 REMARK 465 SER A -4 REMARK 465 ALA A -3 REMARK 465 VAL A -2 REMARK 465 LEU A -1 REMARK 465 GLN A 0 REMARK 465 SER A 301 REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 465 GLY A 307 REMARK 465 PRO A 308 REMARK 465 LEU A 309 REMARK 465 GLU A 310 REMARK 465 HIS A 311 REMARK 465 HIS A 312 REMARK 465 HIS A 313 REMARK 465 HIS A 314 REMARK 465 HIS A 315 REMARK 465 HIS A 316 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -129.39 50.80 REMARK 500 HIS A 41 0.52 -68.90 REMARK 500 ASP A 56 -71.83 -40.50 REMARK 500 ASN A 84 -120.30 54.24 REMARK 500 TYR A 154 -106.74 54.19 REMARK 500 REMARK 500 REMARK: NULL DBREF1 8I4S A -4 306 UNP A0A8B1JQ63_SARS2 DBREF2 8I4S A A0A8B1JQ63 3259 3569 SEQADV 8I4S MET A -18 UNP A0A8B1JQ6 INITIATING METHIONINE SEQADV 8I4S GLY A -17 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S SER A -16 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S SER A -15 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A -14 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A -13 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A -12 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A -11 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A -10 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A -9 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S SER A -8 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S SER A -7 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S GLY A -6 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S MET A -5 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S GLY A 307 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S PRO A 308 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S LEU A 309 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S GLU A 310 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A 311 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A 312 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A 313 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A 314 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A 315 UNP A0A8B1JQ6 EXPRESSION TAG SEQADV 8I4S HIS A 316 UNP A0A8B1JQ6 EXPRESSION TAG SEQRES 1 A 335 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 335 MET SER ALA VAL LEU GLN SER GLY PHE ARG LYS MET ALA SEQRES 3 A 335 PHE PRO SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL SEQRES 4 A 335 THR CYS GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP SEQRES 5 A 335 ASP VAL VAL TYR CYS PRO ARG HIS VAL ILE CYS THR SER SEQRES 6 A 335 GLU ASP MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE SEQRES 7 A 335 ARG LYS SER ASN HIS ASN PHE LEU VAL GLN ALA GLY ASN SEQRES 8 A 335 VAL GLN LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS SEQRES 9 A 335 VAL LEU LYS LEU LYS VAL ASP THR ALA ASN PRO LYS THR SEQRES 10 A 335 PRO LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR SEQRES 11 A 335 PHE SER VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY SEQRES 12 A 335 VAL TYR GLN CYS ALA MET ARG PRO ASN PHE THR ILE LYS SEQRES 13 A 335 GLY SER PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE SEQRES 14 A 335 ASN ILE ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS SEQRES 15 A 335 HIS MET GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP SEQRES 16 A 335 LEU GLU GLY ASN PHE TYR GLY PRO PHE VAL ASP ARG GLN SEQRES 17 A 335 THR ALA GLN ALA ALA GLY THR ASP THR THR ILE THR VAL SEQRES 18 A 335 ASN VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY SEQRES 19 A 335 ASP ARG TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN SEQRES 20 A 335 ASP PHE ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO SEQRES 21 A 335 LEU THR GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER SEQRES 22 A 335 ALA GLN THR GLY ILE ALA VAL LEU ASP MET CYS ALA SER SEQRES 23 A 335 LEU LYS GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR SEQRES 24 A 335 ILE LEU GLY SER ALA LEU LEU GLU ASP GLU PHE THR PRO SEQRES 25 A 335 PHE ASP VAL VAL ARG GLN CYS SER GLY VAL THR PHE GLN SEQRES 26 A 335 GLY PRO LEU GLU HIS HIS HIS HIS HIS HIS HET OU3 A 401 26 HETNAM OU3 3-(4-FLUORANYL-3-METHYL-PHENYL)-2-(2-METHYLPROPYL)-5,6, HETNAM 2 OU3 7-TRIS(OXIDANYL)QUINAZOLIN-4-ONE FORMUL 2 OU3 C19 H19 F N2 O4 FORMUL 3 HOH *152(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 THR A 45 MET A 49 5 5 HELIX 4 AA4 ASN A 53 ARG A 60 1 8 HELIX 5 AA5 SER A 62 HIS A 64 5 3 HELIX 6 AA6 ILE A 200 ASN A 214 1 15 HELIX 7 AA7 THR A 226 TYR A 237 1 12 HELIX 8 AA8 THR A 243 LEU A 250 1 8 HELIX 9 AA9 LEU A 250 GLY A 258 1 9 HELIX 10 AB1 ALA A 260 GLY A 275 1 16 HELIX 11 AB2 THR A 292 CYS A 300 1 9 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N ILE A 78 O LYS A 90 SHEET 1 AA2 5 TYR A 101 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 AA3 3 TYR A 101 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O THR A 175 N MET A 162 CRYST1 98.364 81.332 51.675 90.00 114.74 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010166 0.000000 0.004685 0.00000 SCALE2 0.000000 0.012295 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021308 0.00000